Progyny, Inc. Stock price

Equities

PGNY

US74340E1038

Managed Healthcare

Market Closed - Nasdaq 04:00:00 2023-11-29 pm EST Intraday chart for Progyny, Inc. 5-day change 1st Jan Change
33.99 USD +0.32% +0.65% +9.12%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
Sales 2023 * 1,092 M Sales 2024 * 1,311 M Capitalization 3,257 M
Net income 2023 * 58.00 M Net income 2024 * 72.00 M EV / Sales 2023 *
2,75x
Net cash position 2023 * 254 M Net cash position 2024 * 422 M EV / Sales 2024 *
2,16x
P/E ratio 2023 *
58,6x
P/E ratio 2024 *
48,1x
Employees 397
Yield 2023 *
-
Yield 2024 *
-
Free-Float 91.99%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.32%
1 week+0.65%
Current month+10.14%
1 month+11.48%
3 months-10.03%
6 months-9.09%
Current year+9.12%
More quotes
1 week
33.50
Extreme 33.5
34.74
1 month
29.44
Extreme 29.44
34.74
Current year
28.03
Extreme 28.03
44.95
1 year
28.03
Extreme 28.03
44.95
3 years
25.67
Extreme 25.67
68.32
5 years
13.29
Extreme 13.29
68.32
10 years
13.29
Extreme 13.29
68.32
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 2016
President 46 2021
Director of Finance/CFO 57 2019
Members of the board TitleAgeSince
Director/Board Member 66 2010
Director/Board Member 60 2019
Director/Board Member 74 2016
More insiders
Date Price Change Volume
23-11-29 33.99 +0.32% 498,122
23-11-28 33.88 -0.88% 715,917
23-11-27 34.18 -0.87% 731,625
23-11-24 34.48 +2.10% 387,917
23-11-22 33.77 +2.77% 793,625

Delayed Quote Nasdaq, November 29, 2023 at 04:00 pm EST

More quotes
Progyny, Inc. is a fertility benefits management company. The Company specializes in fertility and family-building benefits solutions in the United States. The Company provides its benefit through its Smart Cycle approach. The Smart Cycles include medical services required for a member's full course of treatment, including all necessary diagnostic testing and access to the technology. In addition, to its fertility benefits solution, it offers an integrated pharmacy benefits solution, Progyny Rx, which is added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. As part of this solution, the Company provides care management services, which include its formulary plan design, simplified authorization, assistance with prescription fulfillment and timely delivery of the medications by its network of specialty pharmacies, as well as medication administration training, pharmacy support services and patient care advocates.
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
33.99USD
Average target price
46.25USD
Spread / Average Target
+36.07%
Consensus
  1. Stock
  2. Equities
  3. Stock Progyny, Inc. - Nasdaq
-40% off Black Friday : Our subscriptions help you unlock the best investment opportunities.
Enjoy this offer